🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsBuyer BewareWhat vendors shut down in 2025? The full list is scary — what worked for you?

What vendors shut down in 2025? The full list is scary — what worked for you?

labquiet_amy Thu, Jul 3, 2025 at 6:06 AM 21 replies 1,548 viewsPage 1 of 5
This thread is more than 11 months old. Information may be outdated. Consider searching for more recent discussions.
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jul 3, 2025 at 6:06 AM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.

Where I think it is weakest: the comparator does most of the work in how this gets reported, and it is not the comparator most people think they are citing.

The narrow version of the question is how people are distinguishing a supplier having a bad batch from a supplier on the way out. Not looking for reassurance. Looking for the part I have got wrong.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
7 2TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 4 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jul 3, 2025 at 6:34 AM#2
labquiet_amy said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

labquiet_amy has the substance of this right. The condition it depends on is worth stating. The useful checklist is about verifiability rather than presentation. Independent test results commissioned by buyers rather than by the seller, consistency across multiple batches over time rather than one flattering report, a physical address and a company registration that resolve, batch and lot numbers on the actual labelling, and a shipping practice that matches what the material needs. Everything a good-looking website provides is cheap to fake; none of the items above are.

Last edited: Jul 3, 2025 at 8:34 AM
6 1PharmD_Rodriguez, julia.endo, JessicaM_2024 and 3 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Jul 3, 2025 at 7:02 AM#3
labquiet_amy said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

I disagree that testing history is decisive. It tells you what a supplier did when they were being watched. Continuity of behaviour under stress — a late shipment, a failed test, a complaint — is more predictive than any run of good results.

5 0HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 2 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Jul 3, 2025 at 7:30 AM#4

Answering the narrow version, because the broad one does not have a single answer. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.

4 24lori_vegas, Dr.PulmRoch, maya_sedona and 1 other
Reply Quote Save Share Report
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Jul 3, 2025 at 10:04 AM#5
LibrarianMeg said:
The useful checklist is about verifiability rather than presentation.

Second this.

3 23SallyK_inj, CryptoCarl, MariaRD
Reply Quote Save Share Report
1235

Similar Threads

⚠ Peptide Sciences SHUT DOWN March 6, 2026 — what happened and what to do now8 replies
⚠ Amino Asylum raided by FDA June 2025 — warehouse seized6 replies
⚠ Swiss Chems FDA warning letter December 2024 — selling unapproved drugs6 replies
⚠ 50+ FDA warning letters sent to peptide vendors in 2025 — full list4 replies
⚠ PeptideMeter exposed: some vendors scoring E grade on basic peptides4 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register